Vertex Pharmaceuticals
Search results
Jun 13, 2024 · mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older. Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older. CAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / ...
Jun 28, 2024 · First large trial suggests mRNA drug gives better protection from SARS-CoV-2 and influenza viruses than single-target shots.
Jun 10, 2024 · Vaccine maker Moderna announced positive late-stage trial results for its Covid-flu combination vaccine. There could be a combined Covid-19 and flu shot in our future, although it won’t be ready...
Jun 13, 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.
Jun 13, 2024 · Moderna said on Thursday its next-generation COVID-19 vaccine candidate showed it was not inferior in efficacy compared to its approved shot in a late-stage study.
Jun 10, 2024 · Moderna is the first company to release positive phase three data on a Covid and flu combination shot, giving it a lead over rivals Pfizer and Novavax.
Jun 10, 2024 · Drug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a single shot, has passed a vital part of final-stage scientific checks.
